Literature DB >> 9916120

Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene.

A M Berry1, A D Ogunniyi, D C Miller, J C Paton.   

Abstract

Pneumolysin is a 471-amino-acid toxin produced by Streptococcus pneumoniae which has both cytolytic and complement activation properties. We have constructed a derivative of the type 2 S. pneumoniae strain D39 in which the portion of the pneumolysin gene encoding amino acids 55 to 437 has been deleted in-frame. The virulence of this strain (DeltaPly) was compared with those of wild-type D39, a pneumolysin insertion-duplication mutant (PLN-A), and a derivative (PdT) carrying a toxin gene with three point mutations known to abolish both cytolytic activity and complement activation. PdT was intermediate in virulence between D39 and either PLN-A or DeltaPly in a mouse intraperitoneal challenge model. This provides unequivocal evidence that pneumolysin has an additional property that is not abolished by point mutations which reduce cytotoxicity and complement activation to virtually undetectable levels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916120      PMCID: PMC96416     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Effect of insertional inactivation of the genes encoding pneumolysin and autolysin on the virulence of Streptococcus pneumoniae type 3.

Authors:  A M Berry; J C Paton; D Hansman
Journal:  Microb Pathog       Date:  1992-02       Impact factor: 3.738

2.  STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III.

Authors:  O T Avery; C M Macleod; M McCarty
Journal:  J Exp Med       Date:  1944-02-01       Impact factor: 14.307

Review 3.  Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae.

Authors:  G J Boulnois; J C Paton; T J Mitchell; P W Andrew
Journal:  Mol Microbiol       Date:  1991-11       Impact factor: 3.501

4.  Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.

Authors:  A M Berry; J Yother; D E Briles; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity.

Authors:  F K Saunders; T J Mitchell; J A Walker; P W Andrew; G J Boulnois
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

6.  Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae.

Authors:  J A Walker; R L Allen; P Falmagne; M K Johnson; G J Boulnois
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

7.  Genetic applications of an inverse polymerase chain reaction.

Authors:  H Ochman; A S Gerber; D L Hartl
Journal:  Genetics       Date:  1988-11       Impact factor: 4.562

8.  Effect of defined point mutations in the pneumolysin gene on the virulence of Streptococcus pneumoniae.

Authors:  A M Berry; J E Alexander; T J Mitchell; P W Andrew; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  Activation of human complement by the pneumococcal toxin pneumolysin.

Authors:  J C Paton; B Rowan-Kelly; A Ferrante
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

10.  Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein.

Authors:  T J Mitchell; P W Andrew; F K Saunders; A N Smith; G J Boulnois
Journal:  Mol Microbiol       Date:  1991-08       Impact factor: 3.501

View more
  40 in total

1.  Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity.

Authors:  Hisashi Baba; Ikuo Kawamura; Chikara Kohda; Takamasa Nomura; Yutaka Ito; Terumi Kimoto; Isao Watanabe; Satoshi Ichiyama; Masao Mitsuyama
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  Peritoneal culture alters Streptococcus pneumoniae protein profiles and virulence properties.

Authors:  C J Orihuela; R Janssen; C W Robb; D A Watson; D W Niesel
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence.

Authors:  Yu-Kuo Tsai; Chang-Phone Fung; Jung-Chung Lin; Jiun-Han Chen; Feng-Yee Chang; Te-Li Chen; L Kristopher Siu
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

4.  Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis.

Authors:  Sonia Manco; Fidelma Hernon; Hasan Yesilkaya; James C Paton; Peter W Andrew; Aras Kadioglu
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

5.  Multiple antigen-presenting system (MAPS) to induce comprehensive B- and T-cell immunity.

Authors:  Fan Zhang; Ying-Jie Lu; Richard Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

6.  Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury.

Authors:  Danielle Salha; Jason Szeto; Lisa Myers; Carol Claus; Anthony Sheung; Mei Tang; Belma Ljutic; David Hanwell; Karen Ogilvie; Marin Ming; Benjamin Messham; Germie van den Dobbelsteen; Robert Hopfer; Martina M Ochs; Scott Gallichan
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

7.  Defective pneumococcal-specific Th1 responses in HIV-infected adults precedes a loss of control of pneumococcal colonization.

Authors:  Sarah J Glennie; Dominic Banda; Kate Gould; Jason Hinds; Arox Kamngona; Dean D B Everett; Neil A Williams; Robert S Heyderman
Journal:  Clin Infect Dis       Date:  2012-09-28       Impact factor: 9.079

8.  Identification of a secreted cholesterol-dependent cytolysin (mitilysin) from Streptococcus mitis.

Authors:  Johanna Jefferies; Leena Nieminen; Lea-Ann Kirkham; Calum Johnston; Andrew Smith; Tim J Mitchell
Journal:  J Bacteriol       Date:  2006-10-27       Impact factor: 3.490

9.  Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin.

Authors:  María del Mar García-Suárez; María Dolores Cima-Cabal; Noelia Flórez; Pilar García; Rafael Cernuda-Cernuda; Aurora Astudillo; Fernando Vázquez; Juan R De los Toyos; F Javier Méndez
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 10.  Potential role for mucosally active vaccines against pneumococcal pneumonia.

Authors:  Kondwani C Jambo; Enoch Sepako; Robert S Heyderman; Stephen B Gordon
Journal:  Trends Microbiol       Date:  2009-12-22       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.